Skip to main content
Caplight Logo









Metri Bio

Metri Bio

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://metri.bio

Last Round

Pre Seed

Dec 2, 2025

Total Funding Raised

$5M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Metri Bio is a biotechnology company that develops first-in-class therapeutics for endometrial diseases using a proprietary 3D endometrial modeling platform.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

endometriosis therapeuticsdrug discoveryorganoid modeling3d tissue modelingbiotechpreclinical developmentendometrial diseasetherapeutic pipelinehuman tissue modelsdrug R&Dorgan-on-a-chipbiopharma partnershipstranslational medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Metri Bio Comparables

Compare Metri Bio with similar companies based on industry and business-model similarity.

Metri Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cyclana Bio
89%
GynQura Therapeutics
88%
FimmCyte
77%

Metri Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedDec 2, 2025

Key People

Founding team and executive leadership

Ashley Abel

CEO & Co-Founder

Founding Team

Metri Bio Investors

Notable investors and investment history

Metri Bio investors
InvestorRounds
Pace VenturesPre Seed
Pillar VCPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 2, 2025

    $5M round led by Pillar VC

Metri Bio Filings

Explore SEC and related filing metadata, where available.

Metri Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Metri Bio's valuation, stock price, and market status.

Is Metri Bio a public or private company?

Metri Bio is a private company.

What is the current stock price of Metri Bio?

Metri Bio is a private company with no public stock price. No recent secondary market data is available.

How much is Metri Bio worth (valuation)?

Valuation information for Metri Bio is not publicly available.

Can I buy Metri Bio stock?

Metri Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Metri Bio's last funding round?

Metri Bio's most recent funding round was Pre Seed on December 2, 2025.

Who are the main investors in Metri Bio?

Key investors in Metri Bio include Pillar VC.

Will Metri Bio IPO soon?

No public IPO plans have been announced for Metri Bio.

How can I track Metri Bio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Metri Bio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range7
Year Founded2025
Last FundingDec 2, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?